Zimmer Biomet considers divesting dental division: 5 things to know


Share on Facebook
After declining dental sales, Zimmer Biomet is contemplating divesting its dental products unit, according to The Wall Street Journal.

Here are five things to know:

1. Zimmer Biomet's dental segment offers various products for dental implants and dental restoration. The company sells to dental practices, laboratories and distributors.

2. In 2017, the dental segmented generated $109 million of the company's full-year earnings before interest, tax, depreciation and amortization.

3. Zimmer Biomet reported the segment's 2017 sales topped $418.6 million, a 2.2 percent decline from the prior year. However, these sales are up from 2015 sales of $335.7 million.

4. The company attributed the dental segment sales decline to restructuring in European markets.

5. Zimmer Biomet hired Bank of America Merrill Lynch as an advisor in advance of a potential sale.

More articles on dental:
Drs. Judy Villanyi, Howard Schneider & more: 5 dentists making headlines
Dentsply Sirona preliminary financial report shows $3.99B in 2017 revenue: 5 insights
SC dentist faces 5 months in prison for tax violations: 3 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months